DMK PHARMACEUTICALS Corp Quarterly Common Stock, Shares, Issued from Q1 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
DMK PHARMACEUTICALS Corp quarterly Common Stock, Shares, Issued history and growth rate from Q1 2011 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 10.1M shares, a 93.3% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 10.1M -140M -93.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 2.8M -148M -98.1% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 167M +16.8M +11.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 2.15M -148M -98.6% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 151M +1.1M +0.73% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 151M +1.1M +0.73% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 150M +847K +0.57% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 150M +55.8M +59.1% Dec 31, 2021 10-K 2023-03-16
Q3 2021 149M +55.2M +58.6% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 149M +75M +101% Jun 30, 2021 10-Q 2021-11-22
Q1 2021 149M +75.2M +101% Mar 31, 2021 10-Q 2021-11-22
Q4 2020 94.4M +32M +51.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 94.2M +32M +51.5% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 74.4M +26.3M +54.6% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 74.3M +26.3M +54.8% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 62.4M +14.5M +30.4% Dec 31, 2019 10-K 2021-04-15
Q3 2019 62.2M +14.3M +30% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 48.2M +14.5M +42.9% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 48M +14.3M +42.3% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 47.8M +14.1M +41.9% Dec 31, 2018 10-K 2020-03-30
Q3 2018 47.8M +14.1M +41.9% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 33.7M +5.72M +20.4% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 33.7M +10.8M +46.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 33.7M +11.4M +51.1% Dec 31, 2017 10-K 2019-03-15
Q3 2017 33.7M +12.5M +58.9% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 28M +10.4M +58.8% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 22.9M +9.18M +66.7% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 22.3M +8.56M +62.3% Dec 31, 2016 10-K 2018-03-16
Q3 2016 21.2M +7.46M +54.3% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 17.6M +3.88M +28.3% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 13.8M +35.7K +0.26% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 13.7M +2.78M +25.4% Dec 31, 2015 10-K 2017-03-30
Q3 2015 13.7M +2.93M +27.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 13.7M +2.93M +27.1% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 13.7M +2.92M +27% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 11M +740K +7.24% Dec 31, 2014 10-K 2016-03-23
Q3 2014 10.8M -99.3M -90.2% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 10.8M -98.8M -90.1% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 10.8M +4.36M +67.6% Mar 31, 2014 10-KT 2015-03-26
Q4 2013 10.2M -98.5M -90.6% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 110M +6.53M +6.31% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 110M +6.28M +6.08% Jun 30, 2013 10-Q 2013-08-19
Q1 2013 6.45M -94.7M -93.6% Mar 31, 2013 10-K 2014-06-23
Q4 2012 109M +10.4M +10.6% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 104M +8.01M +8.38% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 103M +10.3M +11% Jun 30, 2012 10-Q/A 2012-08-17
Q1 2012 101M +14.3M +16.5% Mar 31, 2012 10-K 2013-07-03
Q4 2011 98.4M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 95.6M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 93.1M Jun 30, 2011 10-Q 2011-08-15
Q1 2011 86.8M Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.